BCL2 is a well-established inhibitor of mitochondrial apoptotic pathways, and has emerged as a potential therapeutic target in both leukaemias and solid tumours.27, 28 We therefore decided to focus on the proteins involved in regulation of apoptosis and on BCL2 in particular. The gene discussed is BCL2; the disease is leukemia.